Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 0,33 M
EBIT 2015 -34,5 M
Net income 2015 -34,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 3,67 M
EBIT 2016 -45,6 M
Net income 2016 -45,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 510x
Capi. / Sales 2016 46,4x
Capitalization 170 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Latest news on ANTA PHAR
05/18 ANTHERA PHARMACEUTICALS : Reports 2015 First Quarter and Operational Update
05/12 ANTHERA PHARMACEUTICALS : Reports 2015 First Quarter and Operational Update
05/11 Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update
05/11 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
05/11 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition (form 8-..
04/14 ANTHERA PHARMACEUTICALS : Updates on Biotech Stocks -- Gilead Sciences, Arena Ph..
04/01 ANTHERA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stoc..
03/28 ANTHERA PHARMACEUTICALS : Reports Proposed Public Offering of Common Stock
More news
Sector news : Biopharmaceuticals
05:29p AMGEN : ends work on experimental psoriasis drug
05:26pDJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca
05:13p TSX eases after recent rally as energy, financials slip
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions